Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and other liabilities

v3.20.1
Accrued expenses and other liabilities
3 Months Ended
Mar. 31, 2020
Accrued expenses and other liabilities.  
Accrued expenses and other liabilities

8. Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consist of the following:

 

 

 

 

 

 

 

 

 

 

March 31, 

 

December 31, 

 

    

2020

    

2019

Accrued clinical trial expenses

 

$

625,964

 

$

1,156,618

Compensation and related benefits

 

 

115,348

 

 

303,870

Other expenses

 

 

350,923

 

 

215,979

 

 

$

1,092,235

 

$

1,676,467